AAOS2018: IV-TXA reduces blood loss, not transfusion rate, in reverse total shoulder arthroplasty .
Intravenous Tranexamic Acid Reduces Blood Loss in Reverse Total Shoulder Arthroplasty: A Prospective, Double-Blinded, Randomized, Controlled Trial
102 patients scheduled for reverse total shoulder arthroplasty were randomized to intravenous administration of either tranexamic acid or placebo. Patients were assessed to total blood loss, postoperative blood loss after 24 and 48 hours, hemoglobin drop after 24 and 48 hours, and transfusion requirement. Results demonstrated significantly lower blood loss - total and postoperative - in the IV-TXA group, as well as a significantly smaller drop in Hb level in the IV-TXA group compared to the placebo group. The rate of transfusion did not significantly differ between groups.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
